RECON

EUIPO EUIPO 2017 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark RECON was filed as Word mark on 04/12/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/24/2018. The current status of the mark is "Trademark registered".

Trademark Details Last update: June 14, 2024

Trademark form Word mark
File reference 016606221
Application date April 12, 2017
Publication date September 21, 2017
Entry date July 24, 2018
Expiration date April 12, 2027

Trademark owner

8 The Green Suite B Dover
19901 Kent Country
US

Trademark representatives

Ceresbyen 75 8000 Aarhus C DK

Objection / Complaint

12/21/2017: Identity of marks and G&S Likelihood of confusion
Trademark
Applicant
VITAE HEALTH INNOVATION, S.L.
12/21/2017: Likelihood of confusion
Applicant
Zentiva, a.s.

goods and services

5 Anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; synthetic peptides for the treatment of cancer; and cancer vaccine preparations
42 Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; providing platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials
44 Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals

Trademark history

Date Document number Area Entry
June 13, 2024 Change Representative, Published
May 20, 2020 Transfer / Change of address, Published
December 10, 2019 Change Representative, Published
May 28, 2019 Transfer / Change of address, Published

ID: 11016606221